Scenario
For the creation of the registry that will deal with the identification of the specific disease, the rare disease registry was selected. In particular, this registry will address rare illnesses that should be researched in depth through the implementation of various technologies and scientific studies. Among the crucial and dangerous illnesses that can be included in the rare disease registry is Gaucher Disease (Humi, 2021). Remarkably, this illness is characterized by a mutation in the GBA gene, which is dangerous for the patient’s organs while resulting in such adverse outcomes as anemia. Consequently, when stating the registry’s elements, one should pay attention to the peculiarities of this disease.
As a scenario for creating the rare disease registry, the pandemic related to Gaucher Disease should be considered. Every illness has the potential to overcome specific barriers and start multiplying rapidly. Therefore, in light of the exponential increase in Gaucher disease cases, the United States government decided to establish an effective structure to not only combat the disease but also conduct in-depth research on it (Humi, 2021). As a result, the government established a rare disease registry with a primary focus on the Gaucher Disease pandemic.
Five Elements of the Registry
Patient Identification Code (PID)
- Definition: A unique identifier assigned to each individual enrolled in the Gaucher Disease registry.
- Data Type: Alphanumeric
- Data Format: Unique identifier format (e.g., GD-1234)
- Clinical Technology: Electronic Health Record (EHR) system or registry database.
Date of Diagnosis
- Definition: The date when the patient was diagnosed with Gaucher Disease.
- Data Type: Date
- Data Format: YYYY-MM-DD
- Clinical Technology: Electronic Health Record (EHR) system or clinical data entry interface
Severity Classification
- Definition: Categorization of the severity of Gaucher Disease in the patient, based on clinical manifestations and diagnostic criteria.
- Data Type: Categorical
- Data Format: Text (e.g., Mild, Moderate, Severe)
- Clinical Technology: Clinical assessment tool or research data entry form.
Enzyme Activity Level
- Definition: Measurement of glucocerebrosidase enzyme activity in the patient’s blood or tissues, which is typically reduced in individuals with Gaucher Disease.
- Data Type: Numeric
- Data Format: Units per gram of protein or other standardized units
- Clinical Technology: Laboratory Information Management System (LIMS) or diagnostic testing platform.
Treatment History
- Definition: Documentation of the patient’s history of Gaucher Disease treatments, including enzyme replacement therapy (ERT), substrate reduction therapy (SRT), and other interventions.
- Data Type: Text
- Data Format: Free-text description of treatments received, doses, durations, and treatment responses.
- Clinical Technology: Electronic Health Record (EHR) system or Treatment Management Software.
Results and Conclusion
As a result of the five elements mentioned above, it will be possible to focus on various aspects of illnesses that are not fully researched. Specifically, when considering the peculiarities of Gaucher Disease, elements such as severity classification and Enzyme Activity Level are essential, as they are practical for determining specific symptoms, issues, and potential treatment options (Agrawal & Kosgl, 2022). In addition, the treatment history will allow healthcare professionals to determine specific patterns of the patient’s health state in terms of the rare illness that has been researched. Therefore, one should highlight that both the entire registry and the construction of the five elements are based on the opportunity to research Gaucher Disease by implementing tools such as clinical assessment tools and Electronic Health Record (EHR) systems.
References
Agrawal, A., & Kosgl, S. (2022). Healthcare access. IntechOpen.
Humi, R. (2021). Rare disease drug development: Clinical, scientific, patient, and caregiver perspectives. Springer International Publishing.
